Why are you looking at Global Blood Therapeutics?
Email me when a Global Blood Therapeutics recompete window opens.
Capability
Service linesPHARMACEUTICAL PREPARATION MANUFACTURING · MEDICINAL AND BOTANICAL MANUFACTURING · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
Work mix: 100% prime · 0% sub · primary NAICS 325412 / PSC 6505 DRUGS AND BIOLOGICALS
Where they win
3 agenciesRecompete exposure: Moderate · 3 in 24mo
Global Blood Therapeutics has an estimated $22.2M in contracts returning to market over the next 24 months.
Agency buyer map
3 buyersRecompete exposure
ModerateGlobal Blood Therapeutics has an estimated $22.2M in contracts returning to market over the next 24 months. 2 within 6 months ($11.8M).
“SCOUT saves the hours of analysis that capture and proposal teams cannot afford to lose by delivering analyzed intelligence. Incumbent history, competitive positioning, and agency buying patterns get synthesized into…”
Enter your company name and we'll build the page.
Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →
Frequently asked questions
What federal contracts does Global Blood Therapeutics hold?
Global Blood Therapeutics (UEI MHBQULRMEEJ5) shows $3.2B across 1961 award actions in SCOUT’s public USASpending-backed profile, with Department of Health and Human Services (HHS) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.
How much in federal contracts does Global Blood Therapeutics have?
Global Blood Therapeutics shows $3.2B across 1,961 award actions. SCOUT tracks 3 incumbent recompetes ($22.2M) returning to market in the next 24 months.
Which agencies does Global Blood Therapeutics work with?
Global Blood Therapeutics’s firm-wide obligated mix is led by Department of Health and Human Services (HHS) (100%), Department of Defense (DOD) (0%), Department of Veterans Affairs (VA) (0%).
What is the UEI for Global Blood Therapeutics?
The Unique Entity ID (UEI) for Global Blood Therapeutics is MHBQULRMEEJ5.
Does Global Blood Therapeutics have contracts coming up for recompete?
Yes — SCOUT tracks 3 incumbent recompetes in the next 24 months (Moderate exposure). Open the recompete section on this page for PIID-level timing.
Seen enough? Run one full capture cycle on Global Blood Therapeutics — $90 for 90 days.
This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.
$1/day · one payment · no subscription
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.